11/13
08:05 am
artv
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $23.00 price target on the stock.
High
Report
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $23.00 price target on the stock.
11/12
04:05 pm
artv
Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
High
Report
Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
11/11
04:05 pm
artv
Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference
Low
Report
Artiva Biotherapeutics to Participate in the Jefferies London Healthcare Conference
10/22
04:05 pm
artv
Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors
Medium
Report
Artiva Biotherapeutics Appoints Alison Moore, Ph.D., to Its Board of Directors
9/17
10:14 am
artv
Bicara Therapeutics closes $362m IPO in flurry of biotech listing activity [Yahoo! Finance]
High
Report
Bicara Therapeutics closes $362m IPO in flurry of biotech listing activity [Yahoo! Finance]
9/10
04:05 pm
artv
Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference
Low
Report
Artiva Biotherapeutics to Participate in the 2024 Cantor Fitzgerald Global Healthcare Conference
8/31
12:42 am
artv
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $18.00 price target on the stock.
Medium
Report
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $18.00 price target on the stock.
8/30
12:16 pm
artv
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $23.00 price target on the stock.
Medium
Report
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $23.00 price target on the stock.
8/29
04:13 pm
artv
Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
Low
Report
Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
8/29
04:05 pm
artv
Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Low
Report
Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
8/29
06:03 am
artv
This Biotech IPO Stock Aims to Seize a Multibillion-Dollar Market with Its Innovative Treatment [Yahoo! Finance]
Medium
Report
This Biotech IPO Stock Aims to Seize a Multibillion-Dollar Market with Its Innovative Treatment [Yahoo! Finance]